MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, TXG has $1,041,365K in assets. $245,039K in debts.

Balance Sheets Overview

Current Ratio
446.03%
Quick Ratio
409.31%
Debt to Asset Ratio
23.53%
Assets Breakdown
    • Cash and cash equivalents
    • Property and equipment, net
    • Intangible assets, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, non...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-12-31
Cash and cash equivalents
473,966
Marketable securities
49,443
Accounts receivable, net
47,013
Inventory
56,341
Other receivables
35,480
Prepaid expenses and other current assets
22,208
Total current assets
684,451
Property and equipment, net
226,711
Operating lease right-of-use assets
60,450
Goodwill
4,511
Intangible assets, net
62,329
Other noncurrent assets
2,913
Total assets
1,041,365
Accounts payable
12,733
Deferred revenue
23,902
Contingent consideration, current
23,363
Accrued compensation and related benefits
42,500
Accrued expenses and other current liabilities
39,971
Operating lease liabilities
10,985
Total current liabilities
153,454
Contingent consideration, noncurrent
1,237
Deferred revenue, noncurrent
10,501
Other noncurrent liabilities
6,471
Operating lease liabilities, noncurrent
73,376
Total liabilities
245,039
Common stock, 0.00001 par value 1,100,000,000 shares authorized (class a 1,000,000,000, class b 100,000,000) 127,691,329 (class a 117,612,457, class b 10,078,872) and 122,291,837 (class a 108,235,004, class b 14,056,833) shares issued and outstanding as of december31, 2025 and 2024, respectively
2
Additional paid-in capital
2,306,690
Accumulated deficit
-1,510,591
Accumulated other comprehensive income (loss)
225
Total stockholders equity
796,326
Total liabilities and stockholders equity
1,041,365
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$22,208K Other receivables$35,480K Inventory$56,341K Accounts receivable, net$47,013K Marketable securities$49,443K Cash and cashequivalents$473,966K Other noncurrentassets$2,913K Intangible assets, net$62,329K Goodwill$4,511K Operating leaseright-of-use assets$60,450K Property and equipment,net$226,711K Total current assets$684,451K Total assets$1,041,365K Total liabilities andstockholders equity$1,041,365K Total stockholdersequity$796,326K Total liabilities$245,039K Accumulated deficit-$1,510,591K Accumulated othercomprehensive income (loss)$225K Additional paid-in capital$2,306,690K Operating leaseliabilities, noncurrent$73,376K Other noncurrentliabilities$6,471K Deferred revenue,noncurrent$10,501K Contingent consideration,noncurrent$1,237K Total currentliabilities$153,454K Common stock, 0.00001par value...$2K Operating leaseliabilities$10,985K Accrued expenses andother current...$39,971K Accrued compensationand related...$42,500K Contingent consideration,current$23,363K Deferred revenue$23,902K Accounts payable$12,733K

10x Genomics, Inc. (TXG)

10x Genomics, Inc. (TXG)